Viewing Study NCT03707535


Ignite Creation Date: 2025-12-24 @ 10:10 PM
Ignite Modification Date: 2026-02-20 @ 1:30 PM
Study NCT ID: NCT03707535
Status: COMPLETED
Last Update Posted: 2021-09-14
First Post: 2018-10-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: To Compare the Efficacy, Pharmacokinetics and Safety Between CT-P13 and China Approved Remicade When Co-administered With Methotrexate in Patients With Active Rheumatoid Arthritis
Sponsor: Celltrion
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CT-P13 3.6
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators